Drug Shortage Report for GD-TRANEXAMIC ACID

Last updated on 2020-01-10 History
Report ID 98089
Drug Identification Number 02409097
Brand name GD-TRANEXAMIC ACID
Common or Proper name LEDERLE LEUCOVORIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) TRANEXAMIC ACID
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code B02AA
ATC description ANTIFIBRINOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-06
Estimated end date
Actual end date 2020-01-09
Shortage status Resolved
Updated date 2020-01-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-10 French Compare
v4 2020-01-10 English Compare
v3 2019-12-07 English Compare
v2 2019-11-06 French Compare
v1 2019-11-06 English Compare

Showing 1 to 5 of 5